Neurophysiologic Correlates of Movement Planning During Complex Jump Landing Tasks and the Role of Cognitive Function
NCT03336060, Unknown, Goethe University
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Neurophysiologic Correlates of Movement Planning During Complex Jump Landing Tasks and the Role of Cognitive Function | ClinicalTrials.gov |
| NCT number | NCT03336060 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Enrollment | 50 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Goethe University | ClinicalTrials.gov |
| Conditions | Anterior Cruciate Ligament Reconstruction | ClinicalTrials.gov |
| Interventions | Cortical Correlates of Jump Landing Task | ClinicalTrials.gov |
| First posted | 2017-11-08 | ClinicalTrials.gov |
| Last updated | 2018-03-15 | ClinicalTrials.gov |
Registered outcomes 22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Bereitschaftspotential - Movement planning associated cortical activity measures | Cross sectional design. Time Frame for Assessment of Movement planning associated cortical activity measures (Bereitschaftspotential, low beta-band power, frontal theta-band power) is 4 hours on one day | Determined via Electroencephalography as amplitude in microvolt \[μV\] and latency in milliseconds \[ms\] before initiation of jump movement | ClinicalTrials.gov |
| Primary | Sensorimotor rhythm (SMR)/ low beta-band power - Movement planning associated cortical activity measures | Cross sectional design. Time Frame for Assessment of Movement planning associated cortical activity measures (Bereitschaftspotential, low beta-band power, frontal theta-band power) is 4 hours on one day | Determined via Electroencephalography in microvolt\^2 \[μV²\] | ClinicalTrials.gov |
| Primary | Frontal theta-band power - Movement planning associated cortical activity measures | Cross sectional design. Time Frame for Assessment of Movement planning associated cortical activity measures (Bereitschaftspotential, SMR/ low beta-band power, frontal theta-band power) is 4 hours on one day | Determined via Electroencephalography in microvolt\^2 \[μV²\] | ClinicalTrials.gov |
| Secondary | Peak ground reaction force - Biomechanical outcome measures of single leg jump-landings | Cross sectional design. Biomechanical outcome measures of single leg jump-landings are assessed simultaneously with primary outcome assessment (during same 4 hours on one day) | Determined via capacitive force platform: Biomechanical outcome measure of single leg jump-landing (Newton \[N\]) | ClinicalTrials.gov |
| Secondary | Time to stabilisation - Biomechanical outcome measures of single leg jump-landings | Cross sectional design. Biomechanical outcome measures of single leg jump-landings are assessed simultaneously with primary outcome assessment (during same 4 hours on one day) | Determined via capacitive force platform: Biomechanical outcome measure of single leg jump-landing (seconds \[s\]) | ClinicalTrials.gov |
| Secondary | Center of pressure sway - Biomechanical outcome measures of single leg jump-landings | Cross sectional design. Biomechanical outcome measures of single leg jump-landings are assessed simultaneously with primary outcome assessment (during same 4 hours on one day) | Determined via capacitive force platform: Biomechanical outcome measure of single leg jump-landing (in millimeter \[mm\])\^2 \[μV²\]) | ClinicalTrials.gov |
| Secondary | Visual perceptual ability - Lower cognitive function | Cross sectional design. Timeframe for Assessment is 5 minutes (during congnitive function assessment, separate day as primary outcome assessment) | Determined via pen and paper tests: Trail Making Test A (Time for task completion in seconds \[s\]) | ClinicalTrials.gov |
| Secondary | Reaction time/ processing speed - Lower cognitive function | Cross sectional design. Timeframe for Assessment is 10 minutes (during congnitive function assessment, separate day as primary outcome assessment) | Determined via computer-based neuropsychological test (mean of the log10 transformed reaction times for correct responses in milliseconds \[ms\]) | ClinicalTrials.gov |
| Secondary | Working memory - Higher cognitive function | Cross sectional design. Timeframe for Assessment is 10 minutes (during congnitive function assessment, separate day as primary outcome assessment) | Determined via computer-based neuropsychological test (One card learning test: Speed of performance (mean of the log10 transformed reaction times for correct responses) and Accuracy of performance (arcsine transformation of the square root of the proportion of correct responses); Digit Span Task: Number of correct reproduced digits) | ClinicalTrials.gov |
| Secondary | Cognitive flexibility - Higher cognitive function | Cross sectional design. Timeframe for Assessment is 5 minutes (during congnitive function assessment, separate day as primary outcome assessment) | Determined via pen and paper test: Trail-Making-Test B vs. A (time for task completion in seconds \[s\]) | ClinicalTrials.gov |
| Secondary | Inhibitory control - Higher cognitive function | Cross sectional design. Timeframe for Assessment is 15 minutes (during congnitive function assessment, separate day as primary outcome assessment) | Determined via computer-based neuropsychological test: Stop-Signal-Task (Stop signal reaction time in milliseconds \[ms\]) | ClinicalTrials.gov |
| Secondary | Interference control - Higher cognitive function | Cross sectional design. Timeframe for Assessment is 5 minutes (during congnitive function assessment, separate day as primary outcome assessment) | Determined via pen and paper test: Stroop-Test (Time for task completion in seconds \[s\]) | ClinicalTrials.gov |
| Secondary | Kinesiophobia (subjective measure) - Potential confounder | Cross sectional design. Time Frame for Assessments is 5 minutes (same day as cognitive function assessment) | Determined via questionnaire (Tampa scale) | ClinicalTrials.gov |
| Secondary | Self-reported knee function (subjective measure) - Potential confounder | Cross sectional design. Time Frame for Assessments is 5 minutes (same day as cognitive function assessment) | Determined via questionnaire (Lysholm knee score) | ClinicalTrials.gov |
| Secondary | Physical activities (subjective measure) - Potential confounder | Cross sectional design. Time Frame for Assessments is 5 minutes (same day as cognitive function assessment) | Determined via questionnaire (IPAQ) | ClinicalTrials.gov |
| Secondary | Sport activities (current and past; subjective measure) - Potential confounder | Cross sectional design. Time Frame for Assessments is 5 minutes (same day as cognitive function assessment) | Determined via questionnaire | ClinicalTrials.gov |
| Secondary | Risk behaviour (subjective measure) - Potential confounder | Cross sectional design. Time Frame for Assessments is 5 minutes (same day as cognitive function assessment) | Determined via questionnaire (DOSPERT scale) | ClinicalTrials.gov |
| Secondary | Musculoskeletal injuries (current and past; subjective measure) - Potential confounder | Cross sectional design. Time Frame for Assessments is 5 minutes (same day as cognitive function assessment) | Determined via questionnaire | ClinicalTrials.gov |
| Secondary | Single and both legs jump performance (objective measure) - Potential confounder | Cross sectional design. Time Frame for Assessments is 5 minutes (same day as cognitive function assessment) | Determined via motor testing (in centimeter \[cm\]) | ClinicalTrials.gov |
| Secondary | Single leg jump symmetry (objective measure) - Potential confounder | Cross sectional design. Time Frame for Assessments is 5 minutes (same day as cognitive function assessment) | Determined via motor testing (in percent \[%\]) | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 30232114 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Secondary outcome | ConductCognition |
| Stop-Signal Task | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)